IndiaTicker
Ask IndiaTicker
IndiaTicker account

Keep your research close.

Save companies, build watchlists and return to your work from any device.

New to IndiaTicker? We create your account automatically. No password.

By continuing, you agree to the Terms and Privacy Policy.

Use an existing password
Company dossier

Alembic Pharmaceuticals

NSE:APLLTD · ISIN INE901L01018

Close
₹811.95
29 Jul 2026
Daily change
N/A
Exchange close
Evidence state
Building
0/0 checks
Alembic Pharmaceuticals

Overview

Evidence state

Company record at a glance

Coverage in progress

Latest filing: Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Observed

Latest reported period: 31 Dec 2024 · revenue ₹1,692.7 Cr · PAT ₹137.7 Cr.

Exchange XBRL

Latest ownership: promoter group 69.87% and public 30.13% as of 30 Jun 2026.

Exchange XBRL

Latest rating action: Alembic Pharmaceuticals Limited

Archived report
Material events

What changed recently

Open timeline →
Observed

Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE · exchange filing

Source filing
Observed

Press Release - Alembic Pharmaceuticals Limited

NSE · exchange filing

Source filing
Observed

Analysts/Institutional Investor Meet/Con. Call Updates - Alembic Pharmaceuticals Limited

NSE · conference call

Source filing
Observed

Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE · exchange filing

Source filing
Reported financials

31 Dec 2024

Full financials →
Revenue from operations
₹1,692.7 Cr
Profit after tax
₹137.7 Cr
EPS
₹7.01

Observed NSE structured filing · Consolidated

Ownership

30 Jun 2026

Full shareholding →
Promoter group
69.87%
Public
30.13%
Employee trust
0.00%

Observed NSE shareholding XBRL